Tuesday, August 4, 2026

Pharos iBio Targets Global Licensing Deals, Expands U.S. and European Market Strategy

Pharos iBio aims to secure licensing deals and enhance its AI drug discovery platform for rare diseases, targeting global partnerships.

Depression Linked to Up to 2.4-Fold Higher Risk of Fatty Liver Disease in Young Adults, Study Finds

A South Korean study reveals young adults with depression face double the risk of fatty liver disease compared to those without.

They Were Headed for the Moon—Then Everything Went Wrong

Apollo 13's mission faced disaster after an oxygen tank explosion, but the crew's ingenuity and teamwork led to their safe return.

Tag: investment

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

LG CNS Reports 4.2% Revenue Growth in AI Sector: What This Means for Investors

LG CNS continues to grow in revenue thanks to AI, but profitability has decreased due to expanded investments in the sector.

Samsung Electronics Invests $12.1 Billion in Q2 to Meet Long-Term AI Demand

Samsung Electronics invested $12.1 billion in Q2 2026, focusing on AI-driven demand and expanding manufacturing capacity across sectors.

How DIDEN Robotics is Revolutionizing Shipbuilding with the DIDEN Spider Robot

Diden Robotics seeks 100 billion KRW to expand its quadrupedal robot, the Diden Spider, targeting shipbuilding and humanoid robot markets.

Celltrion Expands PFS Production Capacity to 70 Million: What This Means for the Global Market

Celltrion Pharmaceutical plans to invest 2 trillion KRW to expand its pre-filled syringe production capacity to meet global demand.

Investing in the Future: A Deep Dive into ROBOTIS’s 70 Million USD Physical AI Factory in Uzbekistan

RoboTis is establishing a Physical AI Data Factory in Uzbekistan, combining robotics manufacturing with AI data collection and training.

KT Unveils Ambitious AX Platform Company Vision: What Does This Mean for AI and Cybersecurity in 2026?

KT's CEO unveils a new vision with a $11.85 billion investment in AI, security, and network infrastructure to lead in the AI era.

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Big Pharma Turns to AI, China to Capital—What K-Bio Faced in San Diego [BIO USA Wrap-Up]

The BIO International Convention 2026 highlighted AI's role in biotech, emphasizing supply chain shifts and the need for capital investment.

How Hyundai’s 100 Million USD Investment in Boston Dynamics is Set to Transform Robotics and AI by 2027

Boston Dynamics invests $100M in a new robotics and AI center in Massachusetts to streamline operations and boost job creation by 2033.

Z.ai’s GLM-5.2 Surpasses Google Gemini: What This Means for AI in Asia

ZhipuAI's GLM-5.2 outperforms Google's Gemini, achieving high scores in AI evaluations and offering competitive pricing for its API.

Korean Biopharma Takes Center Stage at BIO USA as Industry Giants and Biotechs Expand Global Reach

The BIO USA 2026 convention gathers over 20,000 bio industry professionals, highlighting the growing presence of Korean companies.

Supply Chains, M&A and AI: As China Closes In, K-Bio Faces a Critical Window of Opportunity [BIO USA]

Korea's biotech industry faces challenges and opportunities amid global restructuring, emphasizing AI and support for startups at BIO USA 2026.

Shaperon Acquires Beauty Device Maker NeedsTech, Targets Revenue Growth in Second Half

Shaperon acquires NeedsTech to diversify into beauty devices, aiming for stable revenue while advancing its biotech pipeline.

Mediwhale Expands Global Digital Health Push With New European Certification for AI Retinal Risk Analysis

Mediwhale is advancing in digital healthcare with AI retinal analysis, securing funding, and aiming for IPO to enhance disease risk prediction.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.